STI Testing & Women’s Health

Sexually transmitted infections (STIs) are diseases caused by microorganisms and viral infections which are spread by sexual contact.

Many STIs are easily treated and cured if diagnosed early, but can have serious consequences if left undiagnosed and untreated. Some people with STIs may not develop symptoms, but they are still at risk for long-term complications and spreading the infection, which is why it’s important to screen for STIs in sexually active individuals.

A balanced vaginal flora helps protect women from other infections.

All the microorganisms that live in and around the vagina make-up a vaginal flora. Healthy vaginal flora are composed primarily of various lactobacilli species which produce substances that discourage the growth of pathogenic microorganisms. Vaginal dysbiosis occurs when there is a loss of commensal lactobacilli and an overgrowth of pathogenic microbes. These dysbiotic conditions include bacterial vaginosis (BV), aerobic vaginitis (AV), and vulvovaginal candidiasis (VVC). Accurate identification of the microorganisms which cause vaginal dysbiosis is essential for proper treatment.

Principle of tests – LifeBrite’s STI and Women’s Health Panels are in vitro, nucleic acid amplification tests (NAAT) designed for use as a screening method for the detection and identification of genomic deoxyribonucleic acid (gDNA) of microorganisms and viral infections associated with Bacterial Vaginosis (BV), Aerobic Vaginitis (AV), Group B Streptococcus (GBS), Urogenital Candidiasis (VVC), and STIs.